A three-component coupling approach to the ACE-ring substructure
K Minagawa et al
5
mixture was extracted with Et2O (10 ml × 3), and the combined organic layers was purified by flash column chromatography on silica gel (4 g, CH2Cl2 to
22
were dried over Na2SO4, filtered and concentrated. The residue was purified by CH2Cl2/EtOAc 10:1). [α]D -65.0 (c 1.00, CHCl3); IR (film) ν 2979, 2934,
flash column chromatography on silica gel (20 g, hexane/EtOAc 80:1 to 10:1) to 2810, 1757, 1706, 1453, 1381, 1242, 1210, 1157, 1112, 1041, 1004, 976 cm− 1
;
afford iodide 1 (309 mg, 916 μmol) in 48% yield over 2 steps: colorless oil; [α] 1H NMR (500 MHz, CDCl3) peaks of the major isomer: δ 1.10 (3H, t, J = 7.5 Hz,
22
− 0.59 (c 1.00, CHCl3); IR (film) ν 2973, 2925, 2894, 2807, 1727, 1452, NCH2CH3), 1.33 (3H, s, acetonide), 1.43 (3H, s, acetonide), 1.50 (1H, m), 1.67
D
1385, 1348, 1318, 1289, 1235, 1202, 1164, 1112, 1020, 965, 935 cm− 1; 1H NMR
(1H, ddd, J =12.6, 12.6, 6.3 Hz), 1.81 (1H, ddd, J = 13.2, 13.2, 6.3 Hz), 1.97
(400 MHz, CDCl3) δ 1.09 (3H, t, J =7.3 Hz, NCH2CH3), 1.44 (1H, m), 1.75
(1H, ddd, J = 13.3, 13.3, 2.3 Hz), 2.34–2.40 (4H, m), 2.74 (1H, ddd, J = 13.3,
13.3, 2.3 Hz), 2.97 (1H, m), 3.09 (1H, d, J = 11.0 Hz), 3.18 (1H, m), 3.31–3.37
(2H, m), 3.34 (3H, s, OMe), 3.44 (1H, d, J = 9.6 Hz), 3.73 (1H, dd, J = 11.0,
2.3 Hz); 13C NMR (100 MHz, CDCl3) δ 12.6, 24.6, 37.5, 49.8, 50.3, 51.6, 59.2,
59.4, 61.9, 71.7, 76.2, 207.3; HRMS (ESI) calcd for C12H20INO2 [M+Na]+
360.0431, found 360.0432.
(1H, m), 2.04 (1H, m), 2.22 (1H, m), 2.38–2.45 (3H, m), 2.53 (1H, d,
J = 11.5 Hz, NCHAHB), 2.63 (1H, dd, J = 19.5, 10.3 Hz), 2.67 (1H, m), 2.76
(1H, d, J = 11.5 Hz, NCHAHB), 2.97 (1H, dd, J = 11.5, 1.7 Hz, NCHAHB), 3.09
(1H, dd, J = 11.5, 1.2 Hz, NCHAHB), 3.26 (1H, d, J = 9.8 Hz, H-18a), 3.32
(3H, s, OMe), 3.36 (1H, d, J = 9.8 Hz, H-18b), 4.61 (1H, d, J = 6.9 Hz, H-12),
4.68 (1H, d, J =6.9 Hz, H-13); 13C NMR (100 MHz, CDCl3) peaks of the major
isomer: δ 12.6, 19.6, 24.7, 26.9, 37.2, 37.8, 38.9, 45.7, 50.2, 51.2, 51.7, 59.6, 62.2,
63.0, 75.8, 79.65, 79.68, 111.8, 212.8, 217.4; HRMS (ESI) calcd for
C20H31NO5Na [M+Na]+ 388.2094, found 388.2088.
General procedure A: two-component radical coupling reaction
Compound 14b
General procedure B: three-component coupling reaction
Et3B (0.99 M in hexane, 370 μl, 370 μmol) was added to a solution of
cyclopentenone 2b (31 μl, 370 μmol) and iodide 1 (41.3 mg, 123 μmol) in Compound 4b
CH2Cl2 (250 μl) at 0 °C over 30 min. The mixture was warmed to room
temperature under air and stirred for 30 min. Then, saturated aqueous
NaHCO3 (2 ml) was added. The resultant mixture was extracted with EtOAc
(2 ml × 3), and the combined organic layers were passed through a pad of silica
gel with EtOAc. After the filtrate was concentrated, the residue was purified by
flash column chromatography on silica gel (4 g, hexane/EtOAc 100:1 to 1:1) to
afford a 1:1 C10-diastereomeric mixture of 14b (23.4 mg, 79.8 μmol) in 65%
Et3B (0.99 M in hexane, 350 μl, 350 μmol) was added to a solution of
cyclopentenone 2a (enantiopure, 75.4 mg, 355 μmol), aldehyde 3b (36 μl,
350 μmol) and iodide 1 (er =9:1, 39.9 mg, 118 μmol) in CH2Cl2 (240 μl) at
0 °C over 30 min. The reaction mixture was warmed to room temperature
under air and stirred for 30 min. Then, saturated aqueous NaHCO3 (2 ml) was
added. The resultant mixture was extracted with EtOAc (2 ml × 3), and the
combined organic layers were passed through a pad of silica gel with EtOAc.
After the filtrate was concentrated, the residue was purified by flash column
chromatography on silica gel (4 g, CH2Cl2/EtOAc 100:1 to 1:1) to afford 4b
(33.2 mg, 62.7 μmol) in 53% yield: colorless oil; [α]D26 3.13 (c 1.00, CHCl3); IR
(film) ν 3462, 2952, 2928, 2894, 2857, 2807, 1708, 1472, 1456, 1388, 1253,
26
yield: [α]D − 0.43 (c 1.00, CHCl3); IR (film) ν 2957, 2930, 1731, 1710, 1459,
1
1362, 1330, 1208, 1165, 1112, 1058 cm− 1; H NMR (500 MHz, CDCl3) δ 1.08
(3H × 1/2, t, J = 6.9 Hz, NCH2CH3), 1.09 (3H × 1/2, t, J = 6.9 Hz, NCH2CH3),
1.40–1.50 (1H, m), 1.63–1.70 (1H, m), 1.73–1.80 (2H, m), 1.95-2.07 (2H, m),
2.10-2.19 (2H, m), 2.21–2.27 (1H, m), 2.29–2.42 (7H, m), 2.72–2.90 (1H, m),
2.92 (1H × 1/2, dd, J = 11.0, 1.8 Hz, NHAHB), 3.01 (1H × 1/2, dd, J = 11.0,
1.8 Hz, NHAHB), 3.14 (1H × 1/2, dd, J = 11.5 Hz, NHAHB), 3.17 (1H × 1/2, dd,
J = 11.5 Hz, NHAHB), 3.29 (1H × 1/2, d, J = 9.2 Hz, H-18a), 3.30 (1H × 1/2, d,
J = 9.2 Hz, H-18a), 3.34 (3H, s, OMe), 3.38 (1H, d, J = 9.2 Hz, H-18b); 13C
NMR (125 MHz, CDCl3) δ 12.56, 12.57, 20.36, 20.37, 20.53, 20.54, 23.4, 23.7,
35.9, 36.3, 36.41, 36.42, 36.52, 36.53, 38.5, 38.7, 39.5, 39.8, 40.9, 41.2, 50.8,
50.9, 51.1, 52.3, 59.2, 59.3, 61.5, 61.6, 63.2, 63.6, 212.5, 212.6, 218.5, 218.7;
HRMS (ESI) calcd for C17H27NO3Na [M+Na]+ 316.1883, found 316.1880.
1172, 1113, 1061 cm−1 1H NMR (400 MHz, CDCl3) δ 0.11 (3H, s, CH3 of
;
TBS), 0.19 (3H, s, CH3 of TBS), 0.94 (9H, s, t-Bu of TBS), 0.98 (3H, t,
J = 6.9 Hz, NCH2CH3), 1.34-1.38 (1H, m), 1.44-1.53 (2H, m), 1.61 (1H, ddd,
J = 12.0, 12.0, 6.3 Hz), 1.68 (1H, br d, J = 10.9 Hz), 2.12-2.19 (5H, m), 2.34
(1H, d, J = 18.9 Hz), 2.36 (1H, m), 2.64 (1H, dd, J = 11.4, 1.8 Hz), 2.64-2.74
(2H, m), 3.02 (1H, dd, J = 11.4, 1.4 Hz), 3.13 (1H, d, J = 9.6 Hz, H-18a), 3.33
(3H, s, OMe), 3.39 (1H, d, J = 9.6 Hz, H-18b), 4.43 (1H, d, J = 6.0 Hz), 4.48
(1H, s), 4.92 (1H, d, J = 7.8 Hz), 7.29-7.38 (5H, m, aromatic); 13C NMR
(100 MHz, CDCl3) δ − 4.6, 12.5, 17.8, 20.0, 25.7, 37.3, 37.4, 49.6, 50.3, 51.2,
52.1, 55.3, 56.7, 59.5, 62.1, 63.1, 71.1, 76.0, 76.3, 127.2, 127.8, 128.2, 141.2,
216.4, 220.4; HRMS (ESI) calcd for C30H47NO5SiNa [M+Na]+ 552.3116, found
552.3117.
Compound 14a
According to the general procedure A, a 9.1:1 mixture of 14a and the
diastereomer presumably originated from the minor enantiomer of
1
(25.7 mg, 60.7 μmol) was obtained in 51% yield by using cyclopentenone 2a
(enantiopure, 75.8 mg, 359 μmol), iodide 1 (er = 9:1, 40.1 mg, 119 μmol) and
Et3B (0.99 M in hexane, 360 μl, 360 μmol) in CH2Cl2 (240 μl). The crude was
purified by flash column chromatography on silica gel (4 g, CH2Cl2/EtOAc
100:1 to 1:1). [α]D 23.0 (c 1.00, CHCl3); IR (film) ν 2950, 2929, 2895, 2808,
1747, 1707, 1470, 1389, 1361, 1254, 1204, 1164, 1112, 1007, 979, 940,
;
908 cm−1 1H NMR (400 MHz, CDCl3) peaks of the major isomer: δ 0.03
(3H, s, CH3 of TBS), 0.07 (3H, s, CH3 of TBS), 0.86 (9H, s, t-Bu of TBS), 1.09
(3H, t, J =7.3 Hz, NCH2CH3), 1.46 (1H, m), 1.65–1.82 (2H, m), 2.15–2.28
(5H, m), 2.33 (1H, d, J = 7.8 Hz), 2.36 (2H, q, J =7.3 Hz, NCH2CH3), 2.58
(1H, d, J = 11 Hz, NCHAHB), 2.70 (1H, dd, J = 17.8, 7.4 Hz), 2.84 (1H, m),
2.95 (1H, dd, J = 11.0, 2.3 Hz, NCHAHB), 3.14 (1H, ddd, J = 11.4, 1.8, 1.8 Hz,
NCHAHB), 3.32 (1H, d, J = 9.6 Hz, H-18a), 3.33 (3H, s, OMe), 3.37 (1H, d,
J = 9.6 Hz, H-18b), 4.50 (1H, dd, J =6.0, 6.0 Hz, H-12); 13C NMR (100 MHz,
CDCl3) peaks of the major isomer: δ − 4.7, −3.9, 12.8, 17.7, 20.4, 25.7, 37.9, 40.3,
40.6, 49.3, 50.4, 50.8, 51.4, 52.0, 59.6, 62.3, 62.8, 70.9, 76.0, 216.1, 217.2; HRMS
(ESI) calcd for C23H41NO4SiNa [M+Na]+ 446.2697, found 446.2708.
Compound 4a
According to the general procedure B, C8(S)-4a (29.0 mg, 52.7 μmol) and C8
(R)-4a (7.4 mg, 13.5 μmol) were obtained in 44% and 11% yields, respectively,
by using cyclopentenone 2a (enantiopure, 76.7 mg, 361 μmol), aldehyde 3a
(53 μl, 361 μmol), iodide 1 (er = 9:1, 40.6 mg, 120 μmol) and Et3B (0.99 M in
hexane, 370 μl, 370 μmol) in CH2Cl2 (240 μl). The crude was purified by flash
column chromatography on silica gel (4 g, CH2Cl2/EtOAc 100:1 to 5:1). C8(S)-
26
26
4a: [α]D − 0.11 (c 1.00, CHCl3); IR (film) ν 3454, 2955, 2929, 2897, 2857,
2809, 2175, 1743, 1709, 1472, 1462, 1388, 1361, 1286, 1251, 1172, 1112, 1066,
1006, 976 cm− 1; 1H NMR (400 MHz, CDCl3) δ 0.07 (3H, s, CH3 of TBS), 0.13
(3H, s, CH3 of TBS), 0.16 (9H, s, CH3 of TMS), 0.86 (9H, s, t-Bu of TBS), 1.09
(3H, t, J = 6.8 Hz, NCH2CH3), 1.49 (1H, m), 1.66 (1H, m), 1.87 (1H, m), 2.02
(1H, m), 2.22-2.41 (7H, m), 2.54 (1H, d, J = 11.0 Hz, NCHAHB), 2.81 (2H, dd,
J = 18.3, 5.5 Hz), 3.01 (1H, d, J = 11.0 Hz, NCHAHB), 3.13 (1H, d, J = 11.0 Hz,
NCHAHB), 3.26 (1H, d, J = 9.6 Hz, H-18a), 3.32 (3H, s, OMe), 3.36 (1H, d,
J = 9.2 Hz, H-18b), 3.70 (1H, s, OH), 4.43 (1H, d, J = 5.5 Hz, H-12), 4.66 (1H,
d, J =7.8 Hz, H-8); 13C NMR (100 MHz, CDCl3) δ − 4.7, − 4.5, − 0.2, 12.7,
17.7, 20.0, 25.6, 37.4, 38.9, 49.1, 50.4, 51.3, 52.3, 55.3, 55.5, 59.6, 62.2, 63.8,
Compound 14c
65.3, 71.0, 75.9, 91.0, 103.6, 216.7, 218.6; HRMS (ESI) calcd for C29H51NO5-
According to the general procedure A, a 14:1 mixture of 14c and the Si2Na [M+Na]+ 572.3198, found 572.3192. C8(R)-4a: [α]D 5.21 (c 1.00,
diastereomer presumably originated from the minor enantiomer of CHCl3); IR (film) ν 3441, 2955, 2929, 2898, 2857, 2810, 2172, 1743, 1713, 1471,
25
1 (23.4 mg, 64.0 μmol) was obtained in 52% yield by using cyclopentenone 1459, 1389, 1250, 1173, 1113, 1065 cm−1; H NMR (400 MHz, CDCl3) δ 0.07
1
2c (enantiopure, 56.8 mg, 368 μmol), iodide 1 (er = 9:1, 41.4 mg, 123 μmol) (3H, s, CH3 of TBS), 0.14 (3H, s, CH3 of TBS), 0.16 (9H, s, CH3 of TMS), 0.87
and Et3B (0.99 M in hexane, 370 μl, 370 μmol) in CH2Cl2 (250 μl). The crude (9H, s, t-Bu of TBS), 1.08 (3H, t, J = 7.3 Hz, NCH2CH3), 1.25 (1H, s, OH),
The Journal of Antibiotics